Total Payments
$4,729
2024 Payments
$1,161
Companies
37
Transactions
244
Medicare Patients
3,118
Medicare Billing
$513,723
Payment Breakdown by Category
Food & Beverage$3,964 (83.8%)
Travel$765.00 (16.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,964 | 242 | 83.8% |
| Travel and Lodging | $765.00 | 2 | 16.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertos Medical, Inc. | $818.07 | 5 | $0 (2024) |
| Abbott Laboratories | $522.45 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $465.96 | 32 | $0 (2019) |
| Medtronic, Inc. | $394.86 | 10 | $0 (2024) |
| TerSera Therapeutics LLC | $248.11 | 14 | $0 (2020) |
| PFIZER INC. | $233.28 | 19 | $0 (2024) |
| Sentynl Therapeutics, Inc. | $231.83 | 21 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $229.05 | 22 | $0 (2020) |
| Nevro Corp. | $192.33 | 10 | $0 (2024) |
| Scilex Pharmaceuticals Inc. | $182.04 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,161 | 21 | Vertos Medical, Inc. ($782.47) |
| 2023 | $586.40 | 18 | Abbott Laboratories ($171.56) |
| 2022 | $408.35 | 11 | Abbott Laboratories ($259.93) |
| 2021 | $401.33 | 17 | Medtronic, Inc. ($120.00) |
| 2020 | $182.29 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.45) |
| 2019 | $778.80 | 54 | TerSera Therapeutics LLC ($229.63) |
| 2018 | $540.76 | 45 | Sentynl Therapeutics, Inc. ($118.70) |
| 2017 | $670.00 | 67 | PFIZER INC. ($129.83) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/28/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: INSTRUMENTS | ||||||
| 10/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 09/16/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| 09/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Neuromodulation | ||||||
| 09/11/2024 | Merit Medical Systems Inc | StabiliT System (Device) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: Surgery | ||||||
| 08/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Neuromodulation | ||||||
| 08/28/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuromodulation | ||||||
| 08/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Neuromodulation | ||||||
| 06/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: PAIN | ||||||
| 03/25/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Orthopedic | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Travel and Lodging | Cash or cash equivalent | $750.00 | General |
| Category: Orthopedic | ||||||
| 02/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PAIN | ||||||
| 01/26/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Orthopedic | ||||||
| 11/03/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/31/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Analgesic | ||||||
| 10/03/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Analgesic | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 952 | 3,182 | $2.5M | $150,731 |
| 2022 | 18 | 899 | 2,993 | $2.2M | $153,894 |
| 2021 | 18 | 976 | 2,266 | $2.4M | $180,048 |
| 2020 | 8 | 291 | 408 | $417,185 | $29,050 |
Total Patients
3,118
Total Services
8,849
Medicare Billing
$513,723
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 296 | 947 | $1.2M | $84,743 | 6.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $123,370 | $9,101 | 7.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 102 | 134 | $105,860 | $8,161 | 7.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 32 | 48 | $56,640 | $7,366 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 100 | $91,000 | $6,965 | 7.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 50 | 60 | $51,780 | $6,728 | 13.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 23 | 29 | $42,978 | $5,648 | 13.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 20 | 20 | $151,636 | $4,220 | 2.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 22 | 37 | $118,448 | $3,527 | 3.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 39 | 54 | $61,032 | $2,558 | 4.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 21 | 35 | $57,960 | $1,891 | 3.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 18 | 20 | $88,974 | $1,830 | 2.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 34 | $40,104 | $1,737 | 4.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 17 | 21 | $62,544 | $1,669 | 2.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 19 | 25 | $78,048 | $1,615 | 2.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $13,560 | $978.67 | 7.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 15 | 17 | $34,165 | $695.47 | 2.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 13 | 17 | $20,052 | $672.66 | 3.4% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 18 | 21 | $10,603 | $448.98 | 4.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 50 | 1,426 | $51,336 | $132.44 | 0.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 52 | $3,744 | $44.00 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 821 | $1.1M | $74,956 | 7.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 118 | 186 | $146,940 | $11,308 | 7.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 42 | 73 | $86,140 | $11,282 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $121,680 | $9,259 | 7.6% |
About Dr. Lane Peterson, DO
Dr. Lane Peterson, DO is a Pain Medicine healthcare provider based in Wesley Chapel, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992711766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lane Peterson, DO has received a total of $4,729 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 244 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,964).
As a Medicare-enrolled provider, Peterson has provided services to 3,118 Medicare beneficiaries, totaling 8,849 services with total Medicare billing of $513,723. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Wesley Chapel, FL
- Active Since 07/31/2006
- Last Updated 10/10/2024
- Taxonomy Code 2081P2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992711766
Products in Payments
- mild Device Kit (Device) $818.07
- PROCLAIM (Device) $406.12
- Morphabond ER (Drug) $391.42
- INTELLIS ADAPTIVESTIM (Device) $274.86
- PRIALT (Drug) $248.11
- Levorphanol (Drug) $194.81
- RELISTOR (Drug) $172.30
- UBRELVY (Drug) $149.97
- ZTLido (Drug) $135.88
- INTELLIS (Device) $120.00
- LYRICA (Drug) $108.94
- NURTEC ODT (Drug) $102.71
- AXIUM (Device) $96.18
- Senza Spinal Cord Stimulation System (Device) $90.43
- Horizant (Drug) $82.29
- RESTORE (Device) $76.35
- Movantik (Drug) $74.54
- Senza (Device) $71.03
- StabiliT System (Device) $70.27
- HYSINGLA ER (Drug) $62.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.